This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Larry B. Goldstein, MD; David B. Matchar, MD

JAMA. 1994;271(14):1114-1120.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

STROKE is the most common serious neurological disorder seen in a general hospital.¹ Each year, approximately 500 000 Americans have strokes. About 150 000 of these individuals die, making stroke the third leading cause of death and the major cause of disability among adults.² Of long-term stroke survivors, approximately 15% require institutional care, 30% are dependent in activities of daily living, and 60% have decreased socialization outside the home.³ The estimated costs of stroke-related care and lost productivity was $18 billion for 1993.² Thus, the costs of stroke are enormous in human and economic terms.

The clinical evaluation of stroke patients often does not receive the attention it deserves. The "therapeutic nihilism" of the past⁴ is disappearing as effective treatments are established by prospective clinical trials. For example, endarterectomy has been shown to be useful in the prevention of major stroke in selected patients with . . . [Full Text PDF of this Article]

Author Affiliations
From the Center for Health Policy Research and Education and the Divisions of Neurology (Dr Goldstein) and General Internal Medicine (Dr Matchar), Department of Medicine, Duke University Medical Center, and Department of Veterans Affairs Medical Center (Drs Goldstein and Matchar), Durham, NC.

Footnotes
Reprint requests to Box 3651, Duke University Medical Center, Durham, NC 27710 (Dr Goldstein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?